Scott Generes

Scott Generes has a strong background in corporate development, business development, finance, and strategic planning. Scott currently holds the role of Vice President of Corporate Development at Travere Therapeutics since September 2022. Prior to this, they were Executive Director of Corporate Development at the same company from April 2021 to September 2022. Scott has also held positions such as Senior Director of Finance and Strategic Planning at Gradalis from October 2015 to March 2017, Director of Strategic Finance at Nestlé Health Science from April 2010 to June 2014, and New Products Planning at Sepracor from September 2008 to March 2010. Overall, Scott's work experience showcases their expertise in strategic planning, finance, and business development across multiple industries.

Scott Generes earned a Bachelor of Science (BS) degree in Genetics from Texas A&M University in 1999. Scott later pursued a Master of Business Administration (MBA) degree from UCLA Anderson School of Management, completing their studies in 2004.